Company Overview
- Headquarters
- 210-887 Great Northern Way, Vancouver BC
- Website
- novartis.com
- Phone
- (510) 848-4400
- Employees
- 170
- Founded in
- 2019
- Industry
- BioTech/Drugs
- NAICS Code
-
NAICS Code 32 CompaniesNAICS Code 3254 CompaniesNAICS Code 325 CompaniesNAICS Code 32541 Companies
- SIC Code
-
SIC Code 2834 CompaniesSIC Code 28 CompaniesSIC Code 283 Companies
Financials & Stats
Revenue
$2B
Total Funding Amount
$171M
Who is Chinook Therapeutics
Chinook Therapeutics is a company based in Vancouver, British Columbia, and is now a subsidiary of Novartis after an acquisition completed on August 11, 2023. The company employs approximately 170 individuals and reported $2 million in revenue. Chinook Therapeutics focuses on the development of innovative therapies for patients with various diseases. Their pipeline includes promising treatments such as atrasentan and zigakibart. As part of the Novartis family, Chinook Therapeutics benefits from the resources and expertise of a global healthcare giant. The company is committed to advancing research and development, ultimately bringing novel treatments to patients in need. For the latest updates on Chinook Therapeutics, including information on atrasentan, zigakibart, and the broader Chinook pipeline, please visit www.novartis.com.
Company Leadership
Chinook Therapeutics Industry Tags
Chinook Therapeutics Tech Stack
Companies Similar to Chinook Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to Chinook Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 2M | 48 | Rockville, MD | 2002 | |
| 2M | 70 | San Diego, CA | 2008 | |
| 2M | 10 | 2018 | ||
| 2M | 8 | Las Vegas, NV | 1998 | |
| 2M | 6 | Gainesville, FL | 2005 |